Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug-receptor interactions in anaesthesia.

Literature DB >> 34992797

Drug-receptor interactions in anaesthesia.

J McDonald¹, D G Lambert¹.

Abstract

Entities: Chemical

Keywords: drug action; opioid; pharmacology; receptors

Year: 2021 PMID： 34992797 PMCID： PMC8703152 DOI： 10.1016/j.bjae.2021.07.009

Source DB: PubMed Journal: BJA Educ ISSN： 2058-5349

Keyword Cloud
References

× No keyword cloud information.

13 in total

1. Cebranopadol, a Novel First-in-Class Analgesic Drug Candidate: First Experience With Cancer-Related Pain for up to 26 Weeks.

Authors: E Dietlind Koch; Sofia Kapanadze; Marie-Henriette Eerdekens; Georg Kralidis; Jiří Létal; Ingo Sabatschus; Sam H Ahmedzai
Journal: J Pain Symptom Manage Date: 2019-05-30 Impact factor: 3.612

Review 2. Opioid receptor subtypes: fact or artifact?

Authors: N Dietis; D J Rowbotham; D G Lambert
Journal: Br J Anaesth Date: 2011-05-24 Impact factor: 9.166

3. Treatment of drug overdosage with naloxone, a specific narcotic antagonist.

Authors: L E Evans; C P Swainson; P Roscoe; L F Prescott
Journal: Lancet Date: 1973-03-03 Impact factor: 79.321

4. Urotensin-II peptidomimetic incorporating a non-reducible 1,5-triazole disulfide bond reveals a pseudo-irreversible covalent binding mechanism to the urotensin G-protein coupled receptor.

Authors: Salvatore Pacifico; Aidan Kerckhoffs; Andrew J Fallow; Rachel E Foreman; Remo Guerrini; John McDonald; David G Lambert; Andrew G Jamieson
Journal: Org Biomol Chem Date: 2017-05-31 Impact factor: 3.876

Review 5. Hot topics in opioid pharmacology: mixed and biased opioids.

Authors: Ammar A H Azzam; John McDonald; David G Lambert
Journal: Br J Anaesth Date: 2019-04-19 Impact factor: 9.166

6. Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic.

Authors: G Calo; D G Lambert
Journal: Br J Anaesth Date: 2018-08-22 Impact factor: 9.166

7. Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.

Authors: Alexander Gillis; Arisbel B Gondin; Andrea Kliewer; Julie Sanchez; Herman D Lim; Claudia Alamein; Preeti Manandhar; Marina Santiago; Sebastian Fritzwanker; Frank Schmiedel; Timothy A Katte; Tristan Reekie; Natasha L Grimsey; Michael Kassiou; Barrie Kellam; Cornelius Krasel; Michelle L Halls; Mark Connor; J Robert Lane; Stefan Schulz; Macdonald J Christie; Meritxell Canals
Journal: Sci Signal Date: 2020-03-31 Impact factor: 8.192